⚖️DEA Revocation of Registration for Dr. Lager-Fermon in Ohio
The Drug Enforcement Administration issued an Order to Show Cause to Dr. Jennifer Marie Lager-Fermon, which proposed revoking her DEA registration due to the indefinite suspension of her Ohio medical license. Consequently, she is no longer authorized to prescribe controlled substances, and the Agency's findings confirmed her default following the lack of a hearing request.
Learn More⚖️DEA Revokes Prescript Pharmaceuticals' Registration for Violations
The Drug Enforcement Administration issued an Order of Revocation against Prescript Pharmaceuticals after it violated federal regulations pertaining to the procurement of controlled substances. The order highlights the importance of compliance with the Controlled Substances Act, especially concerning the requirement for obtaining procurement quotas for manufacturing activities, and could set a precedent affecting other registrants.
Learn More⚖️DEA Denies Registration for Phong Tran, Implicating Business Compliance
The Drug Enforcement Administration (DEA) has denied the application of Dr. Phong H. Tran for a DEA Certificate of Registration due to his exclusion from federal healthcare programs and lack of state authority, highlighting significant regulatory compliance issues for healthcare practitioners and businesses affiliated with them.
Learn More⚖️DEA Revocation Order Impacts Healthcare Business Compliance
The Drug Enforcement Administration (DEA) issued an Order to Show Cause proposing to revoke the registration of Mary Massullo, D.O. due to her lack of authority to handle controlled substances in Ohio, following the permanent revocation of her medical license. The decision emphasizes the importance of compliance with state regulations for medical practitioners and organizations involved in controlled substance handling.
Learn More🌿DEA Notice for Bulk Manufacturer of Marihuana
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More🚫Revocation of DEA Registration for Physician in Georgia
The Drug Enforcement Administration has revoked Dr. Harvey Leslie's DEA registration due to his inability to prescribe controlled substances after the revocation of his Georgia medical license. The document outlines the regulatory process leading to this decision and the implications of default by the registrant.
Learn More💊SpecGx LLC Controlled Substances Import Application Overview
SpecGx LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More🍃DEA Notice on Bulk Manufacturing of Controlled Substances
The Drug Enforcement Administration (DEA) is providing notice of an application it has received from an entity applying to be registered to manufacture in bulk basic class(es) of controlled substances listed in schedule I. DEA intends to evaluate this and other pending applications according to its regulations governing the program of growing marihuana for scientific and medical research under DEA registration.
Learn More🌿Royal Emerald Pharmaceuticals' Application for Controlled Substances Registration
Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More💊Patheon API Services’ Application for Controlled Substances Import
Patheon API Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Learn More